Supporting Complex Protocols with an Integrated EDC and IRT Solution Cara Therapeutics achieves greater agility with Veeva Vault CDMS and Suvoda IRT Cara Therapeutics ran a Phase II randomized study with a protocol typical of the increasingly complex, data-driven approach that the modern clinical trial landscape demands. Thanks to an integration between two best-in-class vendors in EDC and IRT, Cara easily made mid-study changes and managed clinical data. Challenges Time Constraints The company’s fast pace as a clinical-stage biopharmaceutical company meant strict deadlines. Cara’s goal was to use Phase I results collected in the first quarter to inform protocol design and begin implementation of their Phase II trial by the end of the second quarter.

Join for free to read